Biotech company announces the completion of second clinical trial for novel progressive MS therapy
May 10, 2017The last decade has seen the development of a number of new treatments for relapsing forms of MS. Unfortunately, there hasn’t been the same progress in treating progressive forms of the disease. But perhaps the tide is changing. To read more, click on the link below:
Biotech company announces the completion of second clinical trial for novel progressive MS therapy
Article courtesy of MS Research Australia www.msra.org.au